Scarica l'app Stockscreener
16.15
0.31%
-0.05
Dopo l'orario di chiusura:
16.16
0.01
+0.06%
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb CEO, R&D chief to join Goldman Sachs health-care chat - Stock Titan
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results - The AI Journal
Board re-elected, exec pay backed: inside Bausch + Lomb’s 2026 vote - Stock Titan
Bausch + Lomb (BLCO) investors approve board, pay and PwC auditor at 2026 meeting - Stock Titan
Bausch + Lomb unveils PreserVision AREDS3 eye vitamins in the U.S. - Mass Market Retailers
New eye vitamin targets leading cause of vision loss in older Americans - Stock Titan
How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA Momentum - Yahoo Finance
BLCO Stock Price, Quote & Chart | BAUSCH + LOMB CORP (NYSE:BLCO) - ChartMill
Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This Stock - Insider Monkey
BLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
Brent Saunders: Healthcare Innovation Leader, Global Pharmaceutical Executive, and Bausch + Lomb CEO - BBN Times
BLCO (BLCO) CFO has 63,938 shares withheld to cover RSU taxes - Stock Titan
Tax withholding trims Bausch & Lomb (NYSE: BLCO) EVP share count - Stock Titan
Bausch & Lomb (NYSE: BLCO) SVP has 8,673 shares withheld for RSU taxes - Stock Titan
Bausch & Lomb (BLCO) executive reports 11,970-share RSU tax withholding on Form 4 - Stock Titan
Bausch + Lomb launches Bi-Blade+ vitrectomy cutter in Europe - Investing.com
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe - ChartMill
June 1 webinar to detail lens material not seen in 25 years - Stock Titan
Q2 EPS Estimates for Bausch + Lomb Lifted by HC Wainwright - MarketBeat
Bausch & Lomb Earnings: Vision Care Resilience and Pharmaceutical Rebound Lead Off 2026 - Morningstar Canada
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
What Bausch + Lomb (BLCO)'s Upgraded 2026 Outlook and Narrowing Losses Mean For Shareholders - Yahoo Finance
Bausch & Lomb (BLCO) director receives 1,415 restricted share units - Stock Titan
Director at Bausch & Lomb (NYSE: BLCO) granted 1,611 RSUs - Stock Titan
Director John Paulson receives 1,375 RSUs in Bausch & Lomb (NYSE: BLCO) - Stock Titan
Bausch & Lomb (BLCO) director receives 1,375 restricted share units - Stock Titan
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $16 - Moomoo
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Align Tech (ALGN) and Bausch + Lomb Corporation (BLCO) - The Globe and Mail
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2026 Earnings Call Transcript - Insider Monkey
Bausch & Lomb Corp Q1 2026 Financial Results and Risk Factors – Form 10-Q Highlights - Minichart
BofA Securities Maintains Bausch + Lomb Corp.(BLCO.US) With Sell Rating - 富途牛牛
Stifel Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $16 - 富途牛牛
Deutsche Bank Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Cuts Target Price to $16 - 富途牛牛
Bausch + Lomb (NYSE:BLCO) Issues Earnings Results - MarketBeat
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting - BioSpace
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $21 - 富途牛牛
Bausch + Lomb Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
From dry eye to glaucoma, 40+ Bausch + Lomb studies head to Denver - Stock Titan
BofA raises Bausch & Lomb stock price target on earnings beat - Investing.com UK
BofA raises Bausch & Lomb stock price target on earnings beat By Investing.com - Investing.com South Africa
Bausch & Lomb Corp (BLCO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Bausch + Lomb Q1 Earnings Call Highlights - Yahoo Finance
Evercore ISI cuts Bausch & Lomb stock price target on growth outlook - Investing.com India
Evercore ISI cuts Bausch & Lomb stock price target on growth outlook By Investing.com - Investing.com South Africa
Bausch & Lomb 10-Q: Revenue $1,244M, Loss per Share $(0.20) - TradingView
Bausch + Lomb (BLCO) Q1 2026 revenue rises to $1.24B as loss narrows - Stock Titan
Earnings call transcript: Bausch + Lomb exceeds Q1 2026 earnings expectations By Investing.com - Investing.com Australia
Bausch + Lomb Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Bausch + Lomb exceeds Q1 2026 earnings expectations - Investing.com
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026 - Yahoo Finance
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook - The AI Journal
Bausch + Lomb posts Q1 2026 revenue $1.244B, raises FY26 revenue and EBITDA outlook - TradingView
Stronger Q1 2026 drives Bausch + Lomb (NYSE: BLCO) to raise full-year outlook - Stock Titan
Dry-eye and lens sales lift Bausch + Lomb, prompting 2026 raise - Stock Titan
1.39%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):